A new week has begun and it is going to be an interesting one, thanks to the FOMC meeting scheduled for Wednesday that is expected to be a major market-moving event. However, Wall Street earnings season for Q1 2022 is still on the roll therefore individual shares may experience elevated volatility throughout the whole week. The biggest US companies have already reported their earnings, with the majority of US mega techs reporting results last week. Nevertheless, there are still plenty of companies that are yet to show their financials. Among this week's highlights one can find:
-
Advanced Micro Devices (AMD.US)
-
Pfizer (PFE.US)
-
Nikola Corporation (NKLA.US)
-
Virgin Galactic (SPCE.US)
-
Moderna (MRNA.US)
Top Wall Street earnings to watch this week. Source: Bloomberg, XTB
Microsoft: Hedge Fund Sharply Cuts Position and Warns About AI Risks
Cloudflare: strong results, weak outlook, and a painful market reaction
US Open: Earnings season and strong NFP report drive Wall Street higher!
CoreWeave results: Expansion without profit and without direction
The material on this page does not constitute as financial advice and does not take into account your level of understanding, investment objectives, financial situation or any other particular needs.
All the information provided, including opinions, market research, mathematical results and technical analyses published on the website or transmitted to you by other means is provided for information purposes only and should in no event be interpreted as an offer of, or solicitation for, a transaction in any financial instrument, nor should the information provided be construed as advice of legal or fiscal nature.
Any investment decisions you make shall be based exclusively on your level of understanding, investment objectives, financial situation or any other particular needs. Any decision to act on information published on the website or transmitted to you by other means is entirely at your own risk. You are solely responsible for such decisions.
If you are in doubt or are not sure that you understand a particular product, instrument, service, or transaction, you should seek professional or legal advice before trading.
Investing in OTC Derivatives carries a high degree of risk, as they are leveraged based products and often small movements in the market could lead to much larger movements in the value of your investment and this could work against you or for you. Please ensure that you fully understand the risks involved, taking into account your investments objectives and level of experience, before trading, and if necessary, seek independent advice.
